Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech -- Ignore unavailable to you. Want to Upgrade?

To: Larry G. who wrote (707)	5/30/2000 12:02:00 AM
From: Carter Berezay	Read Replies (1) \| Respond to of 792

Larry G., I think MBI will move up when it enters Phase III with 226. My thoughts. 226 is MBI's best drug in development. Second to that is it's acne drug which should take the market by storm. MBI is in a holding pattern right now and should move up going into the second half of this year. Carter B.

To: Larry G. who wrote (707)	5/31/2000 11:27:00 PM
From: Sean Janzen	Respond to of 792

Larry, I can't imagine MBI's share price will jump when MBI enters phase III. This news has been know for quite some time. Remember the slogan, buy on rumor sell on news. MBI has estimated MBI 226 time to market at about 3 years. I think the greatest impact to share price will occur as this time frame shortens. It seems most shareholders on this board feel MBI 226 could reach the market within 24 months. I suspect the stock will trade at $100-200 as MBI 226 nears market. I'm still rejoicing the great gains we have experienced the last 8 months. Sean